Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blockade of CD73 delays glioblastoma growth by modulating the immune environment
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1801-1812
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Glioma targeted therapy: insight into future of molecular approaches
Keyang Yang, Zhijing Wu, Hao Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 483
Emerging therapies for glioblastoma: current state and future directions
Rong Liang, Ni Li, Zhenzhen Zhang
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 302
Immunotherapy for glioblastoma: the promise of combination strategies
Mathilde Bausart, Véronique Préat, Alessio Malfanti
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 144
Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 83
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
Angeliki Datsi, Rüdiger V. Sorg
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them
Karl J. Habashy, Rana Mansour, Charbel Moussalem, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 6, pp. 976-987
Open Access | Times Cited: 46
Tumor-associated macrophage-related strategies for glioma immunotherapy
Fansong Tang, Yuelong Wang, Yunhui Zeng, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 36
The Immune Regulatory Role of Adenosine in the Tumor Microenvironment
Jianlei Xing, Jinhua Zhang, Jinyan Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14928-14928
Open Access | Times Cited: 31
CD73-positive extracellular vesicles promote glioblastoma immunosuppression by inhibiting T-cell clonal expansion
Ming Wang, Jiaoying Jia, Yan Cui, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 53
Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy
Vishawambhar Deshmukh, Nida Sayed Pathan, Niladri Haldar, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114285-114285
Closed Access | Times Cited: 7
Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?
Susan Brandenburg, Anne Blank, Alexander D. Bungert, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 194-194
Open Access | Times Cited: 45
Turning enemies into allies—reprogramming tumor-associated macrophages for cancer therapy
Martina Molgora, Marco Colonna
Med (2021) Vol. 2, Iss. 6, pp. 666-681
Open Access | Times Cited: 37
Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells
Gang Xue, Ziyu Wang, Ningbo Zheng, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1306-1319
Open Access | Times Cited: 29
Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia/macrophages: From basic insights to therapeutic strategies
Yuan Gao, Mengxia Zhang, Guihua Wang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 208, pp. 104649-104649
Closed Access
CD73 Molecule Inhibitor Upregulates miR16 Expression in Experimental Glioblastoma and Inhibits Angiogenesis by Targeting VEGF
Samaneh Arab, Sahar Ghasemi, Marjan Bahraminasab, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 2
Open Access
Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
Mengmeng Fu, Bing Xue, Xiangshui Miao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Acyclic purine and pyrimidine nucleotide analogs as ecto-5’-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Břehová, et al.
European Journal of Medicinal Chemistry (2025), pp. 117653-117653
Open Access
Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017–present)
Alessio Nocentini, Clemente Capasso, Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 10, pp. 867-876
Closed Access | Times Cited: 25
Microglia and macrophages in glioblastoma: landscapes and treatment directions
Georgios Solomou, Adam M. H. Young, Harry Bulstrode
Molecular Oncology (2024)
Open Access | Times Cited: 3
Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
Xin-Qi Teng, Jian Qu, Guohua Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
Gabriela Nogueira Debom, Dominique S. Rubenich, Elizandra Braganhol
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13
CD73 in glioblastoma: Where are we now and what are the future directions?
Nicolly Espindola Gelsleichter, Juliana H. Azambuja, Dominique S. Rubenich, et al.
Immunology Letters (2023) Vol. 256-257, pp. 20-27
Closed Access | Times Cited: 7
EGFR alterations in glioblastoma play a role in antitumor immunity regulation
Xiaopeng Li, Zheng‐Qian Guo, Baofeng Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
Ketao Jin, Chunsen Mao, Lin Chen, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 229-229
Open Access | Times Cited: 17
RNA-encapsulating lipid nanoparticles in cancer immunotherapy: From pre-clinical studies to clinical trials
Tiffaney Hsia, Yunching Chen
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114234-114234
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top